MELI up +1.36% percent Today $MELI High is at 134.39 and

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 10:58 AM

MELI up +1.36% percent Today $MELI High is at 134.39 and the Low 131.63 with current volume of 86,566.

Recent News posted below.

Mercadolibre Inc MELI other info.
http://investorshangout.com/Mercadolibre-MELI-54734/

MELI Mercadolibre Inc Recent Headline News

Amazon Launches New MySQL Compatible Database Aurora - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 3:50PM CST
At its re:Invent developer conference in Las Vegas, Amazon.com (AMZN) unveiled Aurora, a new relational database service. The company took three years to build Aurora.
AMZN: 323.68 (+7.20), BIDU: 247.35 (+3.26), XWES: 5.44 (-0.01), MELI: 133.58 (+1.36)

Make Way for the Much-Awaited "YouTube Music Key" - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 3:29PM CST
Google Inc.'s (GOOGL) YouTube finally rolled out its much awaited Music Key subscription service. The new service marks Google's entry into the increasingly populated music subscription business.
AMZN: 323.69 (+7.21), GOOGL: 554.23 (-2.21), MELI: 133.58 (+1.36), AAPL: 113.62 (+0.80)

Cisco (CSCO) Posts In-Line Q1 Earnings, Beats on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 9:30AM CST
Cisco Systems (CSCO) reported first-quarter fiscal 2015 earnings of 48 cents, in line with the Zacks Consensus Estimate of 48 cents. The adjusted earnings per share exclude one-time items but include stock-based compensation expenses.
T: 35.85 (+0.24), MELI: 133.58 (+1.36), ZU: 28.44 (-0.24), CSCO: 25.96 (+0.28)

Alibaba Hits $9B Singles' Day Sales; Tops Black Friday '13 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 1:10PM CST
Alibaba Group Holding Limited (BABA) Singles' Day sales soared 56.5% to $9 billion from $5.75 billion in 2013, thanks to China's burgeoning Internet population and increasing use of mobile devices.
TSLA: 250.77 (-0.93), COST: 138.58 (-0.13), MELI: 133.58 (+1.36), BABA: 114.23 (-0.61)

Alibaba Founder Plans Alipay IPO, Alliance with Apple Pay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:40AM CST
Chinese e-commerce giant Alibaba Group's (BABA) founder and executive chairman Jack Ma announced his plans to make Alipay, the online payment arm of Alibaba, public.
AMZN: 323.69 (+7.21), MELI: 133.58 (+1.36), AAPL: 113.64 (+0.82), BABA: 114.20 (-0.64)

eBay Collaborates with Mario Wagner to Create ART FOR ALL - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 6:13PM CST
eBay Inc. (EBAY) recently entered into a partnership with artist Mario Wagner to create ART FOR ALL, an Interactive Art Installation in New York City.
ABTL: 11.11 (+0.39), EBAY: 54.32 (-0.05), MELI: 133.58 (+1.36), ZU: 28.44 (-0.24)

Watch for MercadoLibre to Potentially Rebound After Falling 1.18% Yesterday
Comtex SmarTrend(R) - Tue Nov 11, 4:03PM CST
MercadoLibre (NASDAQ:MELI) traded in a range yesterday that spanned from a low of $133.13 to a high of $137.30. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $133.62 on volume of 949,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MELI: 133.58 (+1.36)

MercadoLibre Set to Possibly Rebound After Yesterday's Selloff of 1.18%
Comtex SmarTrend(R) - Tue Nov 11, 4:03PM CST
MercadoLibre (NASDAQ:MELI) traded in a range yesterday that spanned from a low of $133.13 to a high of $137.30. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $133.62 on volume of 949,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MELI: 133.58 (+1.36)

Microsoft Forsakes the Nokia Brand Name for Lumia 535 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:40PM CST
Microsoft Corp. (MSFT) has rolled out a smartphone with an affordable price tag of about $135 as it targets the emerging and other economical markets for growth.
BIDU: 247.35 (+3.26), XWES: 5.44 (-0.01), MELI: 133.58 (+1.36), MSFT: 49.77 (+0.16)

Alibaba Breaks Singles Day Record: $2B in 1 Hour - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 9:24AM CST
Spurred by China's burgeoning Internet population and increasing online retailers, Alibaba Group Holding Limited (BABA) recorded sales volume of more than $2 billion in the first hour and 11 seconds of Nov 11.
TSLA: 250.77 (-0.93), COST: 138.58 (-0.13), MELI: 133.58 (+1.36), BABA: 114.20 (-0.64)

Google Express Chief Goes to Uber - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 3:53PM CST
Car-hailing service Uber has successfully managed to get the head of Google's (GOOGL) Google Express, Tom Fallows, onboard.
BIDU: 247.35 (+3.26), XWES: 5.44 (-0.01), GOOGL: 554.23 (-2.21), MELI: 133.58 (+1.36)

MercadoLibre Earnings Hindsight: Up 17.0% in Last 11 Days (MELI)
Comtex SmarTrend(R) - Mon Nov 10, 12:09PM CST
When MercadoLibre (NASDAQ:MELI) reported earnings 11 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $0.66 on sales of $129.6 million. MercadoLibre actually reported earnings of $0.76 per share on sales of $147.9 million, beating EPS estimates by $0.10 and beating revenue estimates by $18.4 million. Since the company's report, shares of MercadoLibre have risen from $115.20 to $134.75, representing a gain of 17.0% in the past 11 days.
MELI: 133.58 (+1.36)

Insider Trading Alert - MELI, CBT And EXXI Traded By Insiders
at The Street - Mon Nov 10, 11:21AM CST
Stocks with insider trader activity include MELI, CBT and EXXI
EXXI: 6.82 (-0.02), MELI: 133.58 (+1.36), CBT: 46.45 (-0.49)

My Challenges As A Dividend Growth Investor
Integrator - at Seeking Alpha - Fri Nov 07, 4:34PM CST

KO: 42.70 (-0.09), NKE: 95.22 (-0.90), HSY: 95.99 (-0.65), DIS: 90.52 (+0.03), QSII: 15.08 (+0.09), PEP: 98.00 (-0.54), SBUX: 77.96 (+0.07), JNJ: 108.40 (-0.67), V: 249.74 (-1.18), MJN: 100.12 (+0.47), MCD: 96.49 (+1.01), BP: 40.81 (+0.14), PG: 88.61 (+0.01), MELI: 133.58 (+1.36), FHCO: 4.26 (-0.05), CSCO: 25.96 (+0.28), MA: 83.78 (-0.42), CL: 67.97 (-0.32)

Does Google Glass Create Blind Spots for Your Vision? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:22PM CST
While Google Inc. (GOOGL) has been guaranteeing an increased visual experience with on-the-go, hands-free entree to photos, videos,emails, web-surfing and apps with its ground-breaking Google Glass, a recent study has revealed that it runs the risk of creating blind spots.
BIDU: 247.35 (+3.26), XWES: 5.44 (-0.01), GOOGL: 554.23 (-2.21), MELI: 133.58 (+1.36)

Microsemi Tops Q4 Earnings on High Volume; Favorable View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:20AM CST
Microsemi Corporation's (MSCC) adjusted earnings in the fourth quarter of fiscal 2014 of 56 cents per share exceeded the Zacks Consensus Estimate by 4 cents due to higher volume which resulted in stronger revenues.
ABTL: 11.11 (+0.39), MSCC: 27.01 (+0.21), MELI: 133.58 (+1.36), ZU: 28.44 (-0.24)

Autobytel (ABTL) Jumps: Stock Adds 7.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:37AM CST
Autobytel Inc. (ABTL) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
ABTL: 11.11 (+0.39), STMP: 45.36 (+0.05), MELI: 133.58 (+1.36), ZU: 28.44 (-0.24)

Netflix to Enter Australia by 2015, Boosts Overseas Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 4:40PM CST
Netflix, Inc. (NFLX) is reportedly set to hit the Australian market in 2015 with the launch of its services.
NFLX: 380.54 (+1.13), ABTL: 11.11 (+0.39), MELI: 133.58 (+1.36), NWS: 14.93 (+0.12)

Mercadolibre (MELI) & FreightCar America (RAIL): Top Momentum Stocks for November 6th - Video Blog
David Bartosiak - Zacks Investment Research - Thu Nov 06, 12:57PM CST
Mercadolibre (MELI) & FreightCar America (RAIL) are this week's top momentum stocks discussed by Momentum Strategist David Bartosiak.
RAIL: 33.37 (-0.33), MELI: 133.58 (+1.36)

Mercadolibre (MELI) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:07AM CST
Mercadolibre (MELI) Shares March Higher, Can It Continue?
MELI: 133.58 (+1.36)

MercadoLibre Inc. (MELI) Stock Research Links

MELI Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...